R. Lor Randall, MD, FACS

R. Lor Randall, MD, FACS, is the David Linn Endowed Chair for Orthopedic Surgery and chair of the Department of Orthopedic Surgery as well as a professor at the University of California Davis.

Articles

Dr Randall on the Multidisciplinary Foundation of Research Into Sarcoma Survivorship

December 4th 2025

R. Lor Randall, MD, FACS, discusses the multidisciplinary nature of research aiming to develop a predictive model of sarcoma survivorship.

Dr Randall on the Importance of Addressing Socioeconomic Disparities to Improve Sarcoma Survivorship

November 27th 2025

R. Lor Randall, MD, FACS, discusses the potential implications of research into how socioeconomic disparities and cancer biology impact long-term outcomes in pediatric sarcoma.

Dr Randall on the Goals and Methods of Prospective Research on Disparities in Sarcoma Survivorship

November 20th 2025

R. Lor Randall, MD, FACS, outlines the aims and phases of a prospective study evaluating outcome disparities in pediatric sarcoma survivorship care.

Dr Randall on the Need for Precision Survivorship Care in Pediatric and AYA Sarcoma

November 13th 2025

R. Lor Randall, MD, discusses the need to move beyond modest survival improvements in pediatric bone sarcoma toward equitable, precision survivorship care.

Dr Randall on Incorporating Ultrasound STS Surveillance Into Clinical Practice

October 30th 2025

R. Lor Randall, MD, FACS, discusses a new STS surveillance algorithm based on findings that show the comparable diagnostic utility of ultrasound and MRI.

Dr Randall on the Potential Role of Ultrasound in Soft Tissue Sarcoma Surveillance

October 23rd 2025

R. Lor Randall, MD, FACS, summarizes the current status of and future directions for imaging protocols for post-surgical extremity STS surveillance.

Dr Randall on the Diagnostic Accuracy and Cost Effectiveness of MRI vs Ultrasound in STS

October 16th 2025

R. Lor Randall, MD, FACS, compares the diagnostic accuracy, recurrence detection rates, and cost effectiveness of MRI vs ultrasound STS surveillance.

Dr Randall on the Benefits and Limitations of MRI in Soft Tissue Sarcoma Surveillance

October 9th 2025

R. Lor Randall, MD, FACS, discusses the current paradigm and future trajectory of imaging modalities for the surveillance of soft tissue sarcoma.

Dr Randall on Challenges Associated With Incorporating Surgical Protocols Into Sarcoma Clinical Trials

September 30th 2025

R. Lor Randall, MD, FACS, discusses the challenges associated with incorporating surgical protocols into clinical trials evaluating sarcoma treatments.

Dr Randall on Advancing Prosthetic Embodiment in Sarcoma Amputation

September 18th 2025

R. Lor Randall, MD, FACS, discusses future research directions for advancing prosthetic embodiment for patients with sarcoma undergoing amputation.

Dr Randall on the Identification and Management of Non-Ossifying Fibromas

August 29th 2025

R. Lor Randall, MD, FACS, discusses the management of non-ossifying fibromas, and how this differs from that of malignant tumors.

Dr Randall on the Complexity of PEComas

August 19th 2025

R. Lor Randall, MD, FACS, discusses the complexity of perivascular epithelioid cell tumors and the critical importance of multidisciplinary care.

Dr Randall on the Importance of Multidisciplinary Efforts in Sarcoma Management

August 12th 2025

R. Lor Randall, MD, FACS, discusses how suboptimal access to multidisciplinary, coordinated care remains a critical barrier to optimal outcomes in sarcoma.

Dr Randall on Addressing Disparities in Access to Specialized Sarcoma Care

July 14th 2025

R . Lor Randall, MD, FACS, discusses disparities in global access to care for patients with sarcoma.

Dr Randall on the Evolving Role of Surgical Management in Low-Grade Chondrosarcoma

June 27th 2025

R. Lor Randall, MD, FACS discusses the evolving role of surgical management in patients with low-grade chondrosarcoma.

Dr Randall on Consensus Developed at The Annual Birmingham Orthopedic Oncology Meeting

May 27th 2025

R. Lor Randall, MD, FASCO, discusses key areas of consensus discussed at the Annual Birmingham Orthopedic Oncology Meeting.

Dr Randall on the Use of Osteosarcoma Spheroid Models to Streamline Preclinical Therapeutic Development

April 30th 2025

R. Lor Randall, MD, FASCO, discussed the development and application of three-dimensional spheroid models for high-throughput drug screening in osteosarcoma research.

Dr Randall on the Surgical Management of Low-Grade Chondrosarcoma

April 23rd 2025

R. Lor Randall, MD, FACS, discusses whether patients with low-grade chondosarcomas should undergo intralesional curettage or en bloc resection.

Dr Randall on the Applicability of Bioengineered Bone Marrow Models for Metastasis Control in Sarcoma

April 17th 2025

R. Lor Randall, MD, FACS, discusses the benefits of a 3-dimensional model of the sarcoma tumor microenvironment for studying metastasis control mechanisms.

Dr Randall on the Value of Collaborating With Biomedical Engineers to Develop Preclinical Sarcoma Models

April 16th 2025

R. Lor Randall, MD, FACS, discusses the value of collaboration between oncologists and biomedical engineers to develop preclinical sarcoma models.